TORNALATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tornalate, and when can generic versions of Tornalate launch?
Tornalate is a drug marketed by Sanofi Aventis Us and is included in two NDAs.
The generic ingredient in TORNALATE is bitolterol mesylate. Additional details are available on the bitolterol mesylate profile page.
Summary for TORNALATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 27 |
Patent Applications: | 1,259 |
DailyMed Link: | TORNALATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TORNALATE
US Patents and Regulatory Information for TORNALATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | AEROSOL, METERED;INHALATION | 018770-001 | Dec 28, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | SOLUTION;INHALATION | 019548-001 | Feb 19, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TORNALATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | SOLUTION;INHALATION | 019548-001 | Feb 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | SOLUTION;INHALATION | 019548-001 | Feb 19, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | AEROSOL, METERED;INHALATION | 018770-001 | Dec 28, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | AEROSOL, METERED;INHALATION | 018770-001 | Dec 28, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TORNALATE
See the table below for patents covering TORNALATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 131459 | ⤷ Try a Trial | |
Philippines | 14377 | ESTER OF ALPHA-AMINOMETHYL-3-(HYDROXY OR HYDROXYMETHYL)-4-HYDROXYBENZYL KETONES | ⤷ Try a Trial |
Austria | 300762 | ⤷ Try a Trial | |
Finland | 773437 | ⤷ Try a Trial | |
India | 139027 | PREPARATION OF BENZYL KETONES | ⤷ Try a Trial |
Spain | 378092 | ⤷ Try a Trial | |
United Kingdom | 1298771 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |